Unter der Leitung von Johannes Kirchmair vom Department für Pharmazeutische Wissenschaften der Universität Wien werden innovative maschinelle Lernverfahren für die moderne Wirkstoffforschung entwickelt.
The therapies of the future are being developed in Christoph Rademacher's laboratory at the Department of Pharmaceutical Sciences of the University of Vienna. He is currently researching a vaccine patch for home use – and is relying on cooperation with industry.
Ulrike Grienke ist Expertin auf dem Gebiet der Naturstoffe, Lea Ann Dailey hat sich auf die Inhalation von Wirkstoffen spezialisiert. Nun haben sich die beiden Wissenschafterinnen der Uni Wien zusammengetan, um zu untersuchen, wie bestimmte Naturstoffe gegen Corona wirken, wenn sie inhaliert werden....
Originally, Andreas has been looking for natural substances to treat acute respiratory infectious diseases as part of an FWF project. "However, due to the urgency, we focused on finding natural products against SARS-CoV-2" explains the junior researcher and Impact.Award winner in the video.
The Department of Sport Science of the Centre for Sport Science and University Sports has been represented by Barbara Wessner, Astrid Mathy, Christoph Triska (Sports Medicine, Exercise Physiology and Prevention), Robert Csapo, Gustavo Schaun, Peter Raidl, Benedikt Mitter (Training Science), Johanna...
Ammar Tahir (Pharmaceutical Sciences) and Karl-Heinz Wagner (Nutritional Sciences) have been granted an interdisciplinary research project entitled "Lipidomics and Metabolomics Profile Alteration of Elderly People after Vitamin D Supplementation and Strength Training".
On May 20th, more than 50 stations invite visitors to marvel and participate in the in the Long Night of Research in the main building of the University of Vienna, on campus and at other locations.
Peter Raidl, PhD student in Sport Science, participates with the “Experiment: Physical stress...
The team around PhaNuSpo-PI Prof. Judith M. Rollinger from the Department of Pharmaceutical Sciences (Division of Pharmacognosy) is starting a joint project in cooperation with the Schwabe Group.
